05:42 EST Cargo Therapeutics (CRGX) sinks 75% to $3.23 after study failure, analyst downgrades
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CRGX:
- Cargo Therapeutics downgraded to Market Perform from Outperform at William Blair
- Cargo Therapeutics downgraded to Neutral from Overweight at Piper Sandler
- Cargo Therapeutics downgraded to Hold from Buy at Jefferies
- Cargo Therapeutics downgraded to Neutral from Buy at Chardan
- Cargo Therapeutics to discontinue FIRCE-1 Phase 2 study of Firi-cel